VP1 口蹄疫病毒重組單株抗體 |Recombinant monoclonal antibody to VP1貨號Ab00939-2.0
| 代理廠牌： |  |
| 原廠連結： | |
| 相關下載： |
Anti-VP1 [4C4] 口蹄疫病毒重組單株抗體 | 貨號Ab00939-2.0
產品介紹: VP1口蹄疫病毒重組單株抗體 / 小鼠IgG2a，kappa (Clone Number: 4C4)。使用來自雜交瘤4C4的可變區可變區（即特異性）。免疫原針對FMDV的C1型Brescia It / 64菌株產生鼠抗體。特異性：4C4特異性結合C型FMDV衣殼蛋白VP1的G-H環，也稱抗原位點A.這種特異性由斑塊減少中和測定（Verdaguer等人，1999）以及更近期的晶體學數據（Verdaguer等人，1998; Ochoa等人，2000）支持。 VP1是宿主細胞識別所需的外殼蛋白，並且可以促進感染期間的FMDV進入。口蹄疫會影響牛種，在某些情況下可能是致命的。4C4對血清型C FMDV的VP1 G-H環或抗原性位點A具有強烈的中和活性。已經使用噬菌斑減少（中和）測定以及ELISA和免疫印跡（Mateu等人，1992,1989,1990）。
Published Application(s): NTRL; crystallisation; ELISA; WB Published Species Reactivity: Foot-and-mouth disease virus
抗病毒抗體系列商品
Absoluteantibody提供一系列針對病毒抗原的重組抗體。抗體最初通過Hybridoma技術，phage-display噬菌體展示技術或來自感染的人類患者的（永生化）B細胞的sequencing產生。使用Cellclone技術從真實的人類患者中提供了一系列由Humabs BioMed SA產生的抗體。抗體適用於pre-clinical research臨床前研究，並對下列用途進行驗證。
病毒抗體 Anti-VP1 | HA Influenza A Virus 單株抗體 | 牛痘病毒A14磷蛋白 | CHIKV E2 B結構域 | CHIKV E2 B結構域 | E蛋白三聚體（DENV3）
| Product Name | Expected Species Reactivity | Applications |
| Anti-Ebola GP [h-13F6] | EBOV (Zaire) | IP; SPR; ELISA |
| Anti-Ebola Nucleoprotein [KZ51] | Ebola Virus (Zaire, Ivory Coast, Reston, Sudan) | ELISA; WB; IP; IF |
| Anti-Ebola surface glycoprotein [KZ52] | Ebola (Zaire) | NTRL; IF; IP; crystallization |
| Anti-EDIII [2D73] | DENV | ELISA; crystallisation |
| Anti-Envelope dimer Epitope 1 [752-2C8] | Dengue Virus; Zika Virus | NTRL; ELISA; crystallization |
| Anti-Envelope dimer Epitope 1 [753(3) C10] | Dengue Virus; Zika Virus | NTRL; ELISA; crystallization |
| Anti-Envelope dimer Epitope 2 [747(4) A11] | Dengue Virus; Zika Virus | NTRL; ELISA; crystallization |
| Anti-Envelope dimer Epitope 2 [747(4) B7] | Dengue Virus; Zika Virus | NTRL; ELISA; crystallization |
| Anti-Envelope glycoprotein Gc [A5] | Hantavirus | crystallization; SPR |
| Anti-Envelope protein [ZKA64] | Zika Virus | NTRL; enhance; FC; ELISA |
| Anti-Envelope protein [ZKA78] | Zika Virus; Dengue Virus | NTRL; enhance; FC; ELISA |
| Anti-Envelope protein DIII [E111] | DENV-1 | NTRL; FC; WB; IP; IHC; IF |
| Anti-Filovirus GP [Mr78] | Marburg Virus; Ebola Virus | NTRL; ELISA |
| Anti-Flavivirus group antigen [D1-4G2-4-15 (4G2)] | Dengue Virus; Zika Virus; West Nile Virus; Yellow Fever Virus; Flaviviridae | IF; WB; NTRL; ELISA; FC; IHC-P |
| Anti-gH [YC15] | KSHV | WB; NTRL; IHC; FC |
| Anti-gH [YC15] | KSHV | FC; NTRL |
| Anti-Glycoprotein D of HSV [E317] | Herpes Simplex Virus | ELISA; IP; Blocking |
| Anti-Glycoprotein H [A13-d6.3] | pseudorabies virus (PrV) | neutralize; crystalize; immunostaining |
| Anti-GP1 [GD01] | Junin virus (JUNV) | neutralize; crystallize; ELISA |
| Anti-H3N2 antigen from influenza A virus [IF1A11] | Influenza A | ELISA; WB; Blocking |
| Anti-HA [FB75] | Influenza A Virus (several subtypes) | NTRL; ELISA |
| Anti-HA [FC41] | Influenza A Virus (several subtypes) | ELISA |